Tomasz M. Beer, MD completed his medical training at The Johns Hopkins University School of Medicine in 1991 and went on to complete residency training in internal medicine and fellowship training in Hematology and Medical Oncology at Oregon Health & Science University. Dr. Beer serves as the Grover C. Bagby Endowed Chair for Prostate Cancer Research, Professor of Medicine in the Division of Hematology & Medical Oncology and Deputy Director at the Oregon Health and Science University (OHSU), Knight Cancer Institute in Portland. Dr. Beer serves as a leader of the Prostate Cancer Program of the OHSU Knight Cancer Institute and NCI-designated Cancer Center. Dr. Beer has authored and co-authored more than 250 articles and abstracts on prostate cancer. His major research interests include clinical trials, preclinical investigation and risk factors in prostate cancer. Dr. Beer has been involved in more than 100 clinical trials and has led studies that tested new drugs in humans for the first time as well as large global studies that challenge the current standard of care. In addition to developing, carrying out and leading clinical trials, Dr. Beer is strongly interested in bringing knowledge about cancer clinical trials to people living with cancer. During the past year, Dr. Beer teamed up with Larry Axmaker, a cancer survivor and clinical trial participant to author a book entitled Cancer Clinical Trials, A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials. The authors' blog is at www.cancer-clinical-trials.com.